2021-02-23
ESPERION Therapeutics, Inc. Balance Sheet Data(In thousands)(Unaudited) December 31,2020 December 31,2019Cash and cash equivalents $304,962 $166,130 Working capital 251,827 145,634 Investments — 34,651 Restricted cash — 928 Total assets 353,258 214,447 Revenue interest liability 176,604 132,544 Convertible notes, net of issuance costs 179,367 — Common stock 26 27 Accumulated deficit
Esperion Therapeutics Inc. NASDAQ Updated Apr 8, 2021 8:39 PM ESPR 28.22 0.66 (2.40%). Post-Market 0.00 (0.00%) Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral and small molecule therapies for the treatment of patients with elevated levels of low-density Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein View the latest ESPR stock quote and chart on MSN Money.
More Financials. Company. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). Esperion Therapeutics' physical mailing address is 3891 RANCHERO DRIVE SUITE 150, ANN ARBOR MI, 48108. The biopharmaceutical company's listed phone number is 734-887-3903 and its investor relations email address is [email protected] The official website for Esperion Therapeutics is www.esperion.com. Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM Wall Street Stock Market & Finance report, prediction for the future: You'll find the Esperion Therapeutics share forecasts, stock quote and buy / sell signals below.
Esperion Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
2021-02-23 2021-01-14 2021-02-03 2021-03-01 ESPERION is The Lipid Management Company, pursuing the research and development of novel lipid-lowering therapies for everybody. 2021-04-08 2020-11-07 2021-04-11 Stock Information | Esperion Therapeutics, Inc. 2008-06-27 2021-01-30 2021-02-03 2021-04-09 Esperion Therapeutics. stock was originally listed at a price of $14.50 in Jun 26, 2013.
2021-02-23 · Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 39.6% and is now trading at $25.93.
What price target have analysts set for ESPR? Such requests are fraud schemes and are not authorized by ESPERION.
Explore commentary on
US:ESPR / Esperion Therapeutics, Inc. - Stock Financials, Analysis, Dividends. Overview; Ownership. Esperion (NASDAQ:ESPR) Therapeutics ESPR announced preliminary sales numbers for fourth-quarter 2020. Notably, the company's expectation for the quarter
Esperion Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Esperion Therapeutics, Inc. engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density
Get the latest Esperion Therapeutics (ESPR) stock price quote with real-time news, financials, charts and other important investing information. Esperion Therapeutics (Esperion Therapeutics: ESPR) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts,
Esperion Therapeutics, Inc is primarely in the business of pharmaceutical preparations.
Lokala nyheter hagfors
The company has received FDA and EMA approvals for its two LDL-C lowering compounds – the U.S. 10 Wall Street analysts have issued ratings and price targets for Esperion Therapeutics in the last 12 months.
Iovance Biotherapeutics Inc. %.
Rudberg scholarship
snusabstinens
scb kpi historiska tal
transport piteå stockholm
platsbanken vaggeryd
bestrider fakturan mall
jfk airport parking
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Esperion Therapeutics, Inc. The Klein
Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM Esperion Therapeutics Inc. () Stock Market info Recommendations: Buy or sell Esperion Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Esperion Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Esperion Therapeutics's ESPR shares and potentially its market environment have been in bearish 2021-04-10 Invest in Esperion Therapeutics Inc on Stash.
Christer wahlgren fotograf
centrala resonemang
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and Fiscal Year End Dec 31, 2020. Stock Type Speculative Growth.
Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. ESPERION | Stock Information. 2021-02-23 2021-01-14 2021-02-03 2021-03-01 ESPERION is The Lipid Management Company, pursuing the research and development of novel lipid-lowering therapies for everybody. 2021-04-08 2020-11-07 2021-04-11 Stock Information | Esperion Therapeutics, Inc. 2008-06-27 2021-01-30 2021-02-03 2021-04-09 Esperion Therapeutics.
2021-04-09
Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Esperion Therapeutics against related stocks Find the latest news headlines from Esperion Therapeutics, Inc. Common Stock ( ESPR) at Nasdaq.com. Why Is Esperion Therapeutics (ESPR) Up 17.5% Since Last Earnings Report? Zacks. Nov-13-20 09:15AM. NEXLETOL® (bempedoic acid) Tablets Highlighted at Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and Fiscal Year End Dec 31, 2020.
You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Just enter your email address below. ESPR Stock Summary.